Determinants of sensitivity to HER2-targeted antibody drug conjugates in urothelial cancer

Journal:

Nature Communications

Published:

2025-12-20

DOI:

10.1038/s41467-025-67643-2

Affiliations:

13

Authors:

28

Go to article

Institutions	Authors	Share
Memorial Sloan Kettering Cancer Center (MSKCC), United States of America (USA)	18.666667 18.666667	0.67
Human Oncology and Pathogenesis Program (HOPP), MSKCC, United States of America (USA)	5.833333	0.21
Herbert Irving Comprehensive Cancer Center (HICCC), United States of America (USA)	2.000000	0.07
Weill Cornell Medicine, United States of America (USA)	1.500000	0.05

Interested in Oncology and Carcinogenesis?